These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29915400)

  • 1. Office-Based Point of Care Testing (IgA/IgG-Deamidated Gliadin Peptide) for Celiac Disease.
    Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Hadjivassiliou M; Green PHR; Lebwohl B; Sanders DS
    Am J Gastroenterol; 2018 Aug; 113(8):1238-1246. PubMed ID: 29915400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.
    Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Kurien M; Trott N; Leffler DA; Hadjivassiliou M; Sanders DS
    Am J Gastroenterol; 2017 Dec; 112(12):1859-1867. PubMed ID: 29016564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis.
    Volta U; Granito A; Parisi C; Fabbri A; Fiorini E; Piscaglia M; Tovoli F; Grasso V; Muratori P; Pappas G; De Giorgio R
    J Clin Gastroenterol; 2010 Mar; 44(3):186-90. PubMed ID: 20042872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of a novel point-of-care test for simultaneous detection of anti-transglutaminase IgA and anti-deamidated gliadin IgG antibodies.
    Parrinello G; Da Re M; Grizzo F; Camelliti S; Cozzi M; Marinoni F; Villalta D
    J Clin Lab Anal; 2024 Feb; 38(3):e25003. PubMed ID: 38291818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
    Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
    Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
    Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study.
    Tangermann P; Branchi F; Itzlinger A; Aschenbeck J; Schubert S; Maul J; Liceni T; Schröder A; Heller F; Spitz W; Möhler U; Graefe U; Radke M; Trenkel S; Schmitt M; Loddenkemper C; Preiß JC; Ullrich R; Daum S; Siegmund B; Bojarski C; Schumann M
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1780-1787.e5. PubMed ID: 30267867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.
    Tonutti E; Visentini D; Picierno A; Bizzaro N; Villalta D; Tozzoli R; Kodermaz G; Carroccio A; Iacono G; Teresi S; La Chiusa SM; Brusca I
    J Clin Lab Anal; 2009; 23(3):165-71. PubMed ID: 19455636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.
    Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children.
    Basso D; Guariso G; Fogar P; Meneghel A; Zambon CF; Navaglia F; Greco E; Schiavon S; Rugge M; Plebani M
    Clin Chem; 2009 Jan; 55(1):150-7. PubMed ID: 18988751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
    Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
    Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.
    Villalta D; Tonutti E; Prause C; Koletzko S; Uhlig HH; Vermeersch P; Bossuyt X; Stern M; Laass MW; Ellis JH; Ciclitira PJ; Richter T; Daehnrich C; Schlumberger W; Mothes T
    Clin Chem; 2010 Mar; 56(3):464-8. PubMed ID: 20022984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
    Agardh D
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of a new point-of-care screening assay for celiac disease.
    Benkebil F; Combescure C; Anghel SI; Besson Duvanel C; Schäppi MG
    World J Gastroenterol; 2013 Aug; 19(31):5111-7. PubMed ID: 23964145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of commercially available serologic kits for the detection of celiac disease.
    Naiyer AJ; Hernandez L; Ciaccio EJ; Papadakis K; Manavalan JS; Bhagat G; Green PH
    J Clin Gastroenterol; 2009 Mar; 43(3):225-32. PubMed ID: 18724250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
    Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a point-of-care test based on deamidated gliadin peptides for the detection of celiac disease in pediatric patients.
    Polanco I; Koester Weber T; Martínez-Ojinaga E; Molina M; Sarria J
    Rev Esp Enferm Dig; 2017 Nov; 109(11):743-748. PubMed ID: 28950706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of coeliac serological tests: a prospective study.
    Reeves GE; Squance ML; Duggan AE; Murugasu RR; Wilson RJ; Wong RC; Gibson RA; Steele RH; Pollock WK
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):493-501. PubMed ID: 16607143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
    Lau MS; Mooney P; White W; Appleby V; Moreea S; Haythem I; Elias J; Bundhoo K; Corbett G; Wong L; Tsai HH; Cross S; Hebden J; Hoque S; Sanders D
    BMC Gastroenterol; 2016 Sep; 16():115. PubMed ID: 27628523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.